The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Universal Health Services Inc

NYSE: UHS
Last

(U.S.) $136.34

Today's change+4.56 +3.46%
Updated September 2 4:03 PM EDT. Delayed by at least 15 minutes.
 

Universal Health Services Inc

NYSE: UHS
Last

(U.S.) $136.34

Today's change+4.56 +3.46%
Updated September 2 4:03 PM EDT. Delayed by at least 15 minutes.

Universal Health Services Inc up sharply

Universal Health Services Inc closed up sharply Wednesday, rallying (U.S.)$4.56 or 3.46% to (U.S.)$136.34. Shares have lost 0.41% over the last five days, but have gained 22.54% over the last year to date. This security has outperformed the S&P 500 by 21.58% during the last year.

Key company metrics

  • Open(U.S.) $132.78
  • Previous close(U.S.) $131.78
  • High(U.S.) $136.36
  • Low(U.S.) $132.08
  • Bid / Ask-- / --
  • YTD % change+22.54%
  • Volume778,342
  • Average volume (10-day)880,778
  • Average volume (1-month)704,556
  • Average volume (3-month)713,642
  • 52-week range(U.S.) $95.63 to (U.S.) $148.57
  • Beta1.55
  • Trailing P/E22.46×
  • P/E 1 year forward18.83×
  • Forward PEG1.83×
  • Indicated annual dividend(U.S.) $0.40
  • Dividend yield0.29%
  • Trailing EPS(U.S.) $6.07
Updated September 2 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.91%

Based on its net profit margin of 7.91%, Universal Health Services Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.47%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue2,2752,2252,1082,018
Total other revenue--------
Total revenue2,2752,2252,1082,018
Gross profit--------
Total cost of revenue--------
Total operating expense1,9401,8981,7851,841
Selling / general / administrative1,3081,2931,2511,200
Research & development--------
Depreciation / amortization97999893
Interest expense (income), net operating--------
Unusual expense (income)----036
Other operating expenses, total534506436511
Operating income335327322177
Interest income (expense), net non-operating-26-26-27-28
Gain (loss) on sale of assets--------
Other--------
Income before tax308297291144
Income after tax20119419096
Income tax, total10610310148
Net income18217417383
Total adjustments to net income0000
Net income before extra. items18217417383
Minority interest-19-20-18-13
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items18217417383
Inc. avail. to common incl. extra. items18217417383
Diluted net income18217417383
Dilution adjustment------0
Diluted weighted average shares101101101101
Diluted EPS excluding extraordinary itemsvalue per share1.801.731.710.82
Dividends per sharevalue per share0.100.100.100.10
Diluted normalized EPSvalue per share1.801.731.711.06